Bruker Reports Flat Q2 Revenues, Lowers FY 2014 Guidance | GenomeWeb

This story has been updated to include comments from the company's earnings call.

NEW YORK (GenomeWeb News) – Bruker reported after the close of the market Wednesday that its revenues in the second quarter were up by less than one percent year over year, rising to $457.4 million, compared to $454.9 million in Q2 2013.

The results fell slightly short of the average Wall Street estimate of $457.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.